Cover Image
Market Research Report
Product code 
1032221

Anti-Obesity Drugs Market Report 2021-2031: Forecasts by Mechanism of Action, by Type, by Duration, by Distribution Channel, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios

Published: | Visiongain Reports Ltd. | 502 Pages | Delivery time: 1-2 business days

Price

Back to Top
Anti-Obesity Drugs Market Report 2021-2031: Forecasts by Mechanism of Action, by Type, by Duration, by Distribution Channel, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios
Published: September 20, 2021
Visiongain Reports Ltd.
Content info: 502 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Title:
Anti-obesity Drugs Market Report 2021-2031
Forecasts by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI's, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Others), by Type (Prescription Drugs, OTC Drugs), by Duration (Short-Term, Long-Term), by Distribution Channel (Hospitals, Retail, Online) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

Investment in Research, and Innovation is very Modest, Given the Magnitude of the Obesity Problem and its Economic Consequences

Investment in research, innovation, and experimentation is very modest, given the magnitude of the obesity problem and its economic consequences. The United Kingdom, for example, spends less than $1 billion a year on preventive efforts including weight-loss programmes and public health campaigns. To put it in context, it only accounts for approximately 1% of the societal cost of obesity in the UK. More money is needed, particularly to better understand the efficacy of intervention techniques when used as part of a larger programme. However, society should be willing to try out different treatments. Impact data from high-quality, randomised control studies is difficult to come by in many intervention areas. Rather of waiting for such evidence, relevant sections of society should be rational & take action where the risks of intervention are minimal.

Obesity is Being Driven by Social Shifts and a Global Dietary Revolution

The escalating pandemic reflects the significant changes in society and community behaviour patterns over the last several decades. While genes have a role in defining a person's vulnerability to weight gain, calorie intake and physical exercise influence energy balance. As a result, the obesity pandemic is being driven by social shifts and a global dietary revolution. Economic development, industrialization, urbanisation, and food market globalisation are just a few of the factors believed to be driving the pandemic.

Meals rich in complex carbohydrates give way to more diverse diets with a greater percentage of lipids, saturated fats, and sweets as wages increase and people become more urban. Simultaneously, significant changes toward less physically demanding employment have been seen across the globe. Increased use of automated transportation, technology in the house, and more passive leisure activities are all signs of a shift away from physical exercise.

Which Factors are Driving the Global Anti-Obesity Drugs Market?

  • Rising Obesity Awareness to Fuel Market Growth
  • Growing Healthcare Expenditure Anticipated to Drive Market Growth

What are the Market Opportunities for Global Anti-Obesity Drugs Market?

  • Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
  • COVID-19 Pandemic Anticipated to Boost Market Growth
  • Emerging Economies to Offer Lucrative Growth Prospects

Discover how to stay ahead

Our 500+ page report provides 600+ tablesand charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Obesity Drugs Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter's Five Forces, SWOT Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and sub-markets

Mechanism of Action

  • Incretin Mimetics/GLP-1 Agonists
  • Lipase Inhibitors
  • SNDRI's
  • Serotonin Receptor Agonists
  • Sympathomimetic-GABA Receptor Agonists
  • Sympathomimetics
  • Others

Type

  • Prescription Drugs
  • OTC Drugs

Duration

  • Short-Term Anti-Obesity Drugs
  • Long-Term Anti-Obesity Drugs

Distribution Channel

  • Hospitals
  • Retail
  • Online

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

SAMPLE VIEW

Leading companies and the potential for market growth

Overall world revenue for anti-obesity drugs market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Anti-Obesity Drugs Market report helps you

In summary, our 500+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Anti-Obesity Drugs Market, with forecasts for mechanism of action, type, duration and distribution channel, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 18 key national markets- See forecasts for the Anti-Obesity Drugs market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, South-East Asia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 17 of the companies involved in the Anti-Obesity Drugs Market. Some of the company's profiled in this report include Bristol-Myers Squibb, Carmot Therapeutics, CohBar, Currax Pharmaceuticals LLC, Eisai Co. Ltd, ERX Pharmaceuticals, Gelesis, GlaxoSmithKline PLC, Hanmi Pharmaceutical, Co., Ltd., Merck & Co. Inc., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals, Scohia Pharma, Inc., Saniona, Vivus Inc. and YSOPIA Bioscience among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Anti-Obesity Drugs Market and leading companies. You will find data, trends, and predictions.

Product Code: PHA1150

Table of Contents

1. Report Overview

  • 1.1 Introduction to Anti-Obesity Drugs Market
  • 1.2 Anti-Obesity Drugs Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Dynamics

  • 3.1 Drivers
    • 3.1.1 Rising Obesity Awareness to Fuel Market Growth
    • 3.1.2 Growing Healthcare Expenditure Anticipated to Drive Market Growth
  • 3.2 Restraints
    • 3.2.1 Lack of Understanding
    • 3.2.2 Lack of Insurance to Restrain Market Growth
    • 3.2.3 Clinical Trial Enrolment Challenging Market Growth
  • 3.3 Opportunities
    • 3.3.1 Growing Obesity Consciousness Among Public to Offer Lucrative Growth Opportunities
    • 3.3.2 COVID-19 Pandemic Anticipated to Boost Market Growth
    • 3.3.3 Emerging Economies to Offer Lucrative Growth Prospects
  • 3.4 SWOT Analysis
    • 3.4.1 Strengths
    • 3.4.2 Weaknesses
    • 3.4.3 Opportunities
    • 3.4.4 Threats
  • 3.5 Porter's Five Forces Analysis
    • 3.5.1 Buyer Power
    • 3.5.2 Supplier Power
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat of Substitute
    • 3.5.5 Threat of New Entrants
  • 3.6 PEST Analysis
    • 3.6.1 Political Factors Impacting Anti-Obesity Drugs Market
    • 3.6.2 Economic Factors Impacting Anti-Obesity Drugs Market
    • 3.6.3 Social Factors Impacting Anti-Obesity Drugs Market
    • 3.6.4 Technological Factors Impacting Anti-Obesity Drugs Market

4 Anti-Obesity Drugs Market by Mechanism of Action

  • 4.1 Incretin Mimetics/GLP-1 Agonists Segment Market Forecast, 2021-2031
    • 4.1.1 Incretin Mimetics/GLP-1 Agonists Market Overview
    • 4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.2 Lipase Inhibitors Segment Market Forecast, 2021-2031
    • 4.2.1 Lipase Inhibitors Market Overview
    • 4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.3 SNDRI's Segment Market Forecast, 2021-2031
    • 4.3.1 SNDRI's Market Overview
    • 4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.4 Serotonin Receptor Agonists Segment Market Forecast, 2021-2031
    • 4.4.1 Serotonin Market Overview
    • 4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.5 Sympathomimetic-GABA Receptor Agonists Segment Market Forecast, 2021-2031
    • 4.5.1 Sympathomimetic-GABA Receptor Agonists Market Revenue, 2021-2031
    • 4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.6 Sympathomimetics Segment Market Forecast, 2021-2031
    • 4.6.1 Sympathomimetic Market Overview
    • 4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.7 Others Segment Market Forecast, 2021-2031
    • 4.7.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

5 Anti-Obesity Drugs Market by Type

  • 5.1 Prescription Drugs Segment Market Forecast, 2021-2031
    • 5.1.1 Prescription Drugs Market Overview
    • 5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.2 OTC Drugs Segment Market Forecast, 2021-2031
    • 5.2.1 OTC Drugs Market Overview
    • 5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

6 Anti-Obesity Drugs Market by Duration

  • 6.1 Short-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
    • 6.1.1 Short-Term Anti-Obesity Drugs Market Overview
    • 6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.2 Long-Term Anti-Obesity Drugs Segment Market Forecast, 2021-2031
    • 6.2.1 Long-Term Anti-Obesity Drugs Market Overview
    • 6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 Anti-Obesity Drugs Market by Distribution Channel

  • 7.1 Hospitals Segment Market Forecast, 2021-2031
    • 7.1.1 Hospitals Segment Market Overview
    • 7.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 7.2 Retail Segment Market Forecast, 2021-2031
    • 7.2.1 Retail Segment Market Overview
    • 7.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 7.3 Online Segment Market Forecast, 2021-2031
    • 7.3.1 Online Segment Market Overview
    • 7.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

8 Regional and Leading National Anti-Obesity Drugs Market Forecasts 2021-2031

  • 8.1 Global Anti-Obesity Drugs Market by Region Forecast 2021-2031
  • 8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

9 North America Anti-Obesity Drugs Market

  • 9.1 North America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
  • 9.2 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action
  • 9.3 North America Anti-Obesity Drugs Market Forecast by Type
  • 9.4 North America Anti-Obesity Drugs Market Forecast by Duration
  • 9.5 North America Anti-Obesity Drugs Market Forecast by Distribution Channel
  • 9.6 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
    • 9.6.1 U.S. Anti-Obesity Drugs Market Overview
    • 9.6.2 U.S. Anti-Obesity Drugs Market Forecast to 2031
    • 9.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Obesity Drugs Market Forecast, 2021-2031
  • 9.7 Canada Anti-Obesity Drugs Market Forecast, 2021-2031
    • 9.7.1 Canada Anti-Obesity Drugs Market Overview
    • 9.7.2 Canada Anti-Obesity Drugs Market Forecast to 2031
    • 9.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Obesity Drugs Market Forecast, 2021-2031

10 Europe Anti-Obesity Drugs Market

  • 10.1 Europe Anti-Obesity Drugs Market by Country, Forecast 2021-2031
  • 10.2 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action
  • 10.3 Europe Anti-Obesity Drugs Market Forecast by Type
  • 10.4 Europe Anti-Obesity Drugs Market Forecast by Duration
  • 10.5 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel
  • 10.6 Germany Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.6.1 Germany Anti-Obesity Drugs Market Overview
    • 10.6.2 Germany Anti-Obesity Drugs Market Forecast to 2031
    • 10.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.7 UK Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.7.1 UK Anti-Obesity Drugs Market Overview
    • 10.7.2 UK Anti-Obesity Drugs Market Forecast to 2031
    • 10.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.8 France Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.8.1 France Anti-Obesity Drugs Market Overview
    • 10.8.2 France Anti-Obesity Drugs Market Forecast to 2031
    • 10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.9 Italy Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.9.1 Italy Anti-Obesity Drugs Market Overview
    • 10.9.2 Italy Anti-Obesity Drugs Market Forecast to 2031
    • 10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.10 Spain Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.10.1 Spain Anti-Obesity Drugs Market Overview
    • 10.10.2 Spain Anti-Obesity Drugs Market Forecast to 2031
    • 10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.11 Russia Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.11.1 Russia Anti-Obesity Drugs Market Overview
    • 10.11.2 Russia Anti-Obesity Drugs Market Forecast to 2031
    • 10.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Obesity Drugs Market Forecast, 2021-2031
  • 10.12 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031
    • 10.12.1 Rest of Europe Anti-Obesity Drugs Market Overview
    • 10.12.2 Rest of Europe Anti-Obesity Drugs Market Forecast to 2031
    • 10.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031

11 Asia Pacific Anti-Obesity Drugs Market

  • 11.1 Asia Pacific Anti-Obesity Drugs Market by Country, Forecast 2021-2031
  • 11.2 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action
  • 11.3 Asia Pacific Anti-Obesity Drugs Market Forecast by Type
  • 11.4 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration
  • 11.5 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel
  • 11.6 Japan Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.6.1 Japan Anti-Obesity Drugs Market Overview
    • 11.6.2 Japan Anti-Obesity Drugs Market Forecast to 2031
    • 11.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.7 China Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.7.1 China Anti-Obesity Drugs Market Overview
    • 11.7.2 China Anti-Obesity Drugs Market Forecast to 2031
    • 11.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.8 India Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.8.1 India Anti-Obesity Drugs Market Overview
    • 11.8.2 India Anti-Obesity Drugs Market Forecast to 2031
    • 11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.9 Australia Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.9.1 Australia Anti-Obesity Drugs Market Overview
    • 11.9.2 Australia Anti-Obesity Drugs Market Forecast to 2031
    • 11.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.10 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.10.1 South Korea Anti-Obesity Drugs Market Overview
    • 11.10.2 South Korea Anti-Obesity Drugs Market Forecast to 2031
    • 11.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.11 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.11.1 South-East Asia Anti-Obesity Drugs Market Forecast to 2031
    • 11.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031
  • 11.12 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031
    • 11.12.1 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast to 2031
    • 11.12.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031

12 Latin America Anti-Obesity Drugs Market

  • 12.1 Latin America Anti-Obesity Drugs Market by Country, Forecast 2021-2031
  • 12.2 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action
  • 12.3 Latin America Anti-Obesity Drugs Market Forecast by Type
  • 12.4 Latin America Anti-Obesity Drugs Market Forecast by Duration
  • 12.5 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel
  • 12.6 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
    • 12.6.1 Brazil Anti-Obesity Drugs Market Overview
    • 12.6.2 Brazil Anti-Obesity Drugs Market Forecast to 2031
    • 12.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Obesity Drugs Market Forecast, 2021-2031
  • 12.7 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
    • 12.7.1 Mexico Anti-Obesity Drugs Market Overview
    • 12.7.2 Mexico Anti-Obesity Drugs Market Forecast to 2031
    • 12.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Obesity Drugs Market Forecast, 2021-2031
  • 12.8 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031
    • 12.8.1 Rest of Latin America Anti-Obesity Drugs Market Forecast to 2031
    • 12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031

13 Middle East and Africa Anti-Obesity Drugs Market

  • 13.1 Middle East and Africa Anti-Obesity Drugs Market by Country, Forecast 2021-2031
  • 13.2 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action
  • 13.3 MEA Anti-Obesity Drugs Market Forecast by Type
  • 13.4 MEA Anti-Obesity Drugs Market Forecast by Duration
  • 13.5 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel
  • 13.6 GCC Anti-Obesity Drugs Market Forecast, 2021-2031
    • 13.6.1 GCC Anti-Obesity Drugs Market Overview
    • 13.6.2 GCC Anti-Obesity Drugs Market Forecast to 2031
    • 13.6.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Obesity Drugs Market Forecast, 2021-2031
  • 13.7 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
    • 13.7.1 South Africa Anti-Obesity Drugs Market Overview
    • 13.7.2 South Africa Anti-Obesity Drugs Market Forecast to 2031
    • 13.7.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Obesity Drugs Market Forecast, 2021-2031
  • 13.8 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031
    • 13.8.1 Rest of MEA Anti-Obesity Drugs Market Overview
    • 13.8.2 Rest of MEA Anti-Obesity Drugs Market Forecast to 2031
    • 13.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031

14 Company Profiles

  • 14.1 Bristol-Myers Squibb
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
    • 14.1.4 Product Benchmarking
    • 14.1.5 Recent Developments
  • 14.2 Currax Pharmaceuticals LLC
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Product Benchmarking
    • 14.2.4 Recent Developments
  • 14.3 Eisai Co. Ltd
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
    • 14.3.4 Product Benchmarking
    • 14.3.5 Recent Developments
  • 14.4 GlaxoSmithKline PLC
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
    • 14.4.4 Product Benchmarking
    • 14.4.5 Recent Developments
  • 14.5 Merck & Co. Inc.
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
    • 14.5.4 Product Benchmarking
    • 14.5.5 Recent Developments
  • 14.6 Novo Nordisk A/S
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
    • 14.6.4 Product Benchmarking
    • 14.6.5 Recent Developments
  • 14.7 Pfizer Inc.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
    • 14.7.4 Product Benchmarking
    • 14.7.5 Recent Developments
  • 14.8 Rhythm Pharmaceuticals
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
    • 14.8.4 Product Benchmarking
    • 14.8.5 Recent Developments
  • 14.9 Vivus Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
    • 14.9.4 Product Benchmarking
    • 14.9.5 Recent Developments
  • 14.10 ERX Pharmaceuticals
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Product Benchmarking
  • 14.11 CohBar
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
    • 14.11.4 Product Benchmarking
  • Recent Developments
  • 14.12 Carmot Therapeutics
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Product Benchmarking
  • 14.13 YSOPIA Bioscience
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product Benchmarking
  • 14.14 Gelesis
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Product Benchmarking
  • 14.15 Scohia Pharma, Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Product Benchmarking
  • 14.16 Hanmi Pharmaceutical, Co., Ltd.
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
    • 14.16.4 Product Benchmarking
  • 14.17 Saniona
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Product Benchmarking

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Global Anti-Obesity Drugs Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
  • Table 2 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 3 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 4 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 5 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 6 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 7 Global Anti-Obesity Drugs Market Forecast for Incretin Mimetics/GLP-1 Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 8 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 9 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 10 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 11 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 12 Global Anti-Obesity Drugs Market Forecast for Lipase Inhibitors Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 13 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 14 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 15 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 16 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 17 Global Anti-Obesity Drugs Market Forecast for SNDRI's Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 18 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 19 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 20 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 21 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 22 Global Anti-Obesity Drugs Market Forecast for Serotonin Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 23 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 24 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 25 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 26 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 27 Global Anti-Obesity Drugs Market Forecast for Sympathomimetic-GABA Receptor Agonists Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 28 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 29 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 30 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 31 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 32 Global Anti-Obesity Drugs Market Forecast for Sympathomimetics Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 33 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 34 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 35 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 36 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 37 Global Anti-Obesity Drugs Market Forecast for Others Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 38 Global Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 39 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 40 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 41 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 42 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 43 Global Anti-Obesity Drugs Market Forecast for Prescription Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 44 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 45 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 46 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 47 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 48 Global Anti-Obesity Drugs Market Forecast for OTC Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 49 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 50 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 51 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 52 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 53 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 54 Global Anti-Obesity Drugs Market Forecast for Short-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 55 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 56 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 57 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 58 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 59 Global Anti-Obesity Drugs Market Forecast for Long-Term Anti-Obesity Drugs Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 60 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 61 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 62 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 63 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 64 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 65 Global Anti-Obesity Drugs Market Forecast for Hospitals Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 66 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 67 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 68 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 69 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 70 Global Anti-Obesity Drugs Market Forecast for Retail Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 71 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 72 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 73 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 74 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 75 Global Anti-Obesity Drugs Market Forecast for Online Segment, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 76 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 77 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 78 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 79 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 80 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 81 North America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 82 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 83 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 84 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 85 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 86 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 87 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 88 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 89 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 90 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 91 North America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 92 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 93 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 94 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 95 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 96 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 97 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 98 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 99 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 100 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 101 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 102 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 103 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 104 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 105 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 106 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 107 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 108 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 109 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 110 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 111 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 112 Europe Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 113 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 114 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 115 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 116 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 117 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 118 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 119 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 120 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 121 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 122 Europe Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 123 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 124 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 125 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 126 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 127 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 128 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 129 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 130 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 131 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 132 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 133 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 134 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 135 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 136 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 137 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 138 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 139 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 140 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 141 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 142 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 143 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 144 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 145 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 146 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 147 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 148 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 149 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 150 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 151 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 152 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 153 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 154 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 155 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 156 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 157 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 158 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 159 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 160 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 161 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 162 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 163 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 164 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 165 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 166 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 167 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 168 Asia Pacific Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 169 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 170 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 171 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 172 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 173 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 174 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 175 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 176 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 177 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 178 Asia Pacific Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 179 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 181 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 189 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 190 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 191 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 192 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 193 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 194 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 195 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 196 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 197 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 198 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 199 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 200 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 201 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 202 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 203 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 204 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 205 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 206 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 207 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 208 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 209 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 210 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 211 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 212 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 213 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 214 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 215 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 216 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 217 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 218 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 219 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 220 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 221 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 222 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 223 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 224 Latin America Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 225 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 226 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 227 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 228 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 229 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 230 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 231 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 232 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 233 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 234 Latin America Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 235 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 236 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 237 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 238 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 239 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 240 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 241 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 242 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 243 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 244 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 245 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 246 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 247 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 248 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 249 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 250 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 251 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 252 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 253 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 254 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 255 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 256 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 257 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 258 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 259 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 260 MEA Anti-Obesity Drugs Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 261 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 262 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 263 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 264 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 265 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 266 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 267 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 268 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 269 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 270 MEA Anti-Obesity Drugs Market Forecast by Prescription, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 271 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 272 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 273 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 274 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 275 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 276 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 277 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 278 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 279 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 280 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 281 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 282 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 283 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 284 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 285 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 286 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 287 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 288 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 289 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 290 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 291 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 292 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 293 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 294 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 295 Rest of MEA Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 296 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 297 Bristol-Myers Squibb: Product Benchmarking
  • Table 298 Bristol-Myers Squibb: Recent Developments
  • Table 299 Currax Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 300 Currax Pharmaceuticals LLC: Product Benchmarking
  • Table 301 Currax Pharmaceuticals LLC: Recent Developments
  • Table 302 Eisai Co. Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 303 Eisai Co. Ltd: Product Benchmarking
  • Table 304 Eisai Co. Ltd: Recent Developments
  • Table 305 GlaxoSmithKline PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 306 GlaxoSmithKline PLC: Product Benchmarking
  • Table 307 GlaxoSmithKline PLC: Recent Developments
  • Table 308 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 309 Merck & Co. Inc.: Product Benchmarking
  • Table 310 Merck & Co. Inc.: Recent Developments
  • Table 311 Novo Nordisk A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 312 Novo Nordisk A/S: Product Benchmarking
  • Table 313 Novo Nordisk A/S: Recent Developments
  • Table 314 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 315 Pfizer Inc.: Product Benchmarking
  • Table 316 Pfizer Inc.: Recent Developments
  • Table 317 Rhythm Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 318 Rhythm Pharmaceuticals: Product Benchmarking
  • Table 319 Rhythm Pharmaceuticals: Recent Developments
  • Table 320 Vivus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 321 Vivus Inc.: Product Benchmarking
  • Table 322 Vivus Inc.: Recent Developments
  • Table 323 ERX Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 324 ERX Pharmaceuticals: Product Benchmarking
  • Table 325 CohBar: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 326 CohBar: Product Benchmarking
  • Table 327 CohBar: Recent Developments
  • Table 328 Carmot Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 329 Carmot Therapeutics: Product Benchmarking
  • Table 330 YSOPIA Bioscience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 331 YSOPIA Bioscience: Product Benchmarking
  • Table 332 Gelesis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 333 Gelesis: Product Benchmarking
  • Table 334 Scohia Pharma, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 335 Scohia Pharma, Inc.: Product Benchmarking
  • Table 336 Hanmi Pharmaceutical, Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 337 Hanmi Pharmaceutical, Co., Ltd.: Product Benchmarking
  • Table 338 Saniona: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 339 Saniona: Product Benchmarking

List of Figures

  • Figure 1 Global Anti-Obesity Drugs Market: Market Segmentation
  • Figure 2 Global Anti-Obesity Drugs Market Attractiveness Index
  • Figure 3 Global Anti-Obesity Drugs Market: DROC
  • Figure 4 Global Anti-Obesity Drugs Market: SWOT Analysis
  • Figure 5 Porter's Analysis
  • Figure 6 PEST Analysis
  • Figure 7 Global Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR %)
  • Figure 8 Global Anti-Obesity Drugs Market Share Forecast by Mechanism of Action, 2021, 2026, 2031 (%)
  • Figure 9 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 10 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 11 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 12 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 13 Global Anti-Obesity Drugs Market for Incretin Mimetics/GLP-1 Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 14 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 15 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 16 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 17 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 18 Global Anti-Obesity Drugs Market for Lipase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 19 Global Anti-Obesity Drugs Market for SNDRI's Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 20 Global Anti-Obesity Drugs Market for SNDRI's Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 21 Global Anti-Obesity Drugs Market for SNDRI's Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 22 Global Anti-Obesity Drugs Market for SNDRI's Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 23 Global Anti-Obesity Drugs Market for SNDRI's Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 24 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 25 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 26 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 27 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 28 Global Anti-Obesity Drugs Market for Serotonin Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 29 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 30 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 31 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 32 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 33 Global Anti-Obesity Drugs Market for Sympathomimetic-GABA Receptor Agonists Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 34 Global Anti-Obesity Drugs Market for Sympathomimetics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 35 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 36 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 37 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 38 Global Anti-Obesity Drugs Market for Sympathomimetics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 39 Global Anti-Obesity Drugs Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 40 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 41 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 42 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 43 Global Anti-Obesity Drugs Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 44 Global Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR %)
  • Figure 45 Global Anti-Obesity Drugs Market Share Forecast by Type, 2021, 2026, 2031 (%)
  • Figure 46 Global Anti-Obesity Drugs Market for Prescription Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 47 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 48 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 49 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 50 Global Anti-Obesity Drugs Market for Prescription Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 51 Global Anti-Obesity Drugs Market for OTC Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 52 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 53 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 54 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 55 Global Anti-Obesity Drugs Market for OTC Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 56 Global Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR %)
  • Figure 57 Global Anti-Obesity Drugs Market Share Forecast by Duration, 2021, 2026, 2031 (%)
  • Figure 58 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 59 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 60 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 61 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 62 Global Anti-Obesity Drugs Market for Short-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 63 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 64 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 65 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 66 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 67 Global Anti-Obesity Drugs Market for Long-Term Anti-Obesity Drugs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 68 Global Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR %)
  • Figure 69 Global Anti-Obesity Drugs Market Share Forecast by Distribution Channel, 2021, 2026, 2031 (%)
  • Figure 70 Global Anti-Obesity Drugs Market for Hospitals Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 71 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 72 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 73 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 74 Global Anti-Obesity Drugs Market for Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 75 Global Anti-Obesity Drugs Market for Retail Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 76 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 77 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 78 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 79 Global Anti-Obesity Drugs Market for Retail Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 80 Global Anti-Obesity Drugs Market for Online Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 81 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 82 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 83 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 84 Global Anti-Obesity Drugs Market for Online Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 85 Global Anti-Obesity Drugs Market Forecast by Region 2021-2031 (US$ million)
  • Figure 86 Global Anti-Obesity Drugs Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 87 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 88 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 89 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 90 Global Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 91 North America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
  • Figure 92 North America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 93 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
  • Figure 94 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 95 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 96 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 97 North America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 98 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
  • Figure 99 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 100 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 101 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 102 North America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 103 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
  • Figure 104 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 105 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 106 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 107 North America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 108 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 109 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 110 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 111 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 112 North America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 113 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 114 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 115 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 116 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 117 U.S. Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 118 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 119 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 120 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 121 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 122 Canada Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 123 Europe Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
  • Figure 124 Europe Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 125 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
  • Figure 126 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 127 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 128 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 129 Europe Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 130 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
  • Figure 131 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 132 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 133 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 134 Europe Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 135 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
  • Figure 136 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 137 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 138 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 139 Europe Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 140 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 141 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 142 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 143 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 144 Europe Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 145 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 146 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 147 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 148 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 149 Germany Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 150 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 151 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 152 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 153 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 154 UK Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 155 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 156 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 157 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 158 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 159 France Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 160 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 161 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 162 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 163 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 164 Italy Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 165 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 166 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 167 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 168 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 169 Spain Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 170 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 171 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 172 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 173 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 174 Russia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 175 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 176 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 177 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 178 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 179 Rest of Europe Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 180 Asia Pacific Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
  • Figure 181 Asia Pacific Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 182 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
  • Figure 183 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 184 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 185 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 186 Asia Pacific Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 187 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
  • Figure 188 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 189 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 190 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 191 Asia Pacific Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 192 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
  • Figure 193 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 194 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 195 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 196 Asia Pacific Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 197 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 198 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 199 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 200 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 201 Asia Pacific Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 202 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 203 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 204 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 205 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 206 Japan Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 207 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 208 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 209 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 210 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 211 China Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 212 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 213 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 214 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 215 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 216 India Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 217 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 218 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 219 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 220 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 221 Australia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 222 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 223 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 224 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 225 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 226 South Korea Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 227 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 228 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 229 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 230 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 231 South-East Asia Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 232 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 233 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 234 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 235 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 236 Rest of Asia Pacific Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 237 Latin America Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
  • Figure 238 Latin America Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 239 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
  • Figure 240 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 241 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 242 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 243 Latin America Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 244 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
  • Figure 245 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 246 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 247 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 248 Latin America Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 249 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
  • Figure 250 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 251 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 252 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 253 Latin America Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 254 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 255 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 256 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 257 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 258 Latin America Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 259 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 260 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 261 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 262 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 263 Brazil Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 264 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 265 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 266 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 267 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 268 Mexico Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 269 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 270 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 271 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 272 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 273 Rest of Latin America Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 274 Middle East and Africa Anti-Obesity Drugs Market Forecast by Country 2021-2031 (US$ million)
  • Figure 275 Middle East and Africa Anti-Obesity Drugs Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 276 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%)
  • Figure 277 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 278 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 279 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 280 MEA Anti-Obesity Drugs Market Forecast by Mechanism of Action, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 281 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%)
  • Figure 282 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 283 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 284 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 285 MEA Anti-Obesity Drugs Market Forecast by Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 286 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%)
  • Figure 287 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 288 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 289 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 290 MEA Anti-Obesity Drugs Market Forecast by Duration, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 291 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 292 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 293 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 294 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 295 MEA Anti-Obesity Drugs Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 296 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 297 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 298 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 299 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 300 GCC Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 301 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 302 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 303 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 304 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 305 South Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 306 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 307 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 308 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 309 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 310 Rest of Middle East and Africa Anti-Obesity Drugs Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 311 Bristol-Myers Squibb: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 312 Bristol-Myers Squibb: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 313 Bristol-Myers Squibb: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 314 Eisai Co. Ltd: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 315 Eisai Co. Ltd: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 316 Eisai Co. Ltd: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 317 GlaxoSmithKline PLC: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 318 GlaxoSmithKline PLC: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 319 GlaxoSmithKline PLC: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 320 Merck & Co. Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 321 Merck & Co. Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 322 Merck & Co. Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 323 Novo Nordisk A/S: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 324 Novo Nordisk A/S: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 325 Novo Nordisk A/S: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 326 Pfizer Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 327 Pfizer Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 328 Pfizer Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 329 Rhythm Pharmaceuticals: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 330 Vivus Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 331 Vivus Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 332 Vivus Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 333 CohBar: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 334 Hanmi Pharmaceutical, Co., Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)

Companies Profiled in the Report:

  • Bristol-Myers Squibb
  • Carmot Therapeutics
  • CohBar
  • Currax Pharmaceuticals LLC
  • Eisai Co. Ltd
  • ERX Pharmaceuticals
  • Gelesis
  • GlaxoSmithKline PLC
  • Hanmi Pharmaceutical, Co., Ltd.
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Rhythm Pharmaceuticals
  • Saniona
  • Scohia Pharma, Inc.
  • Vivus Inc.
  • YSOPIA Bioscience

List of Other Companies:

  • Adipo Therapeutics
  • Allurion Technologies
  • Calibrate
  • CiiTECH
  • EnteroMedics
  • EraCal Therapeutics
  • Form Health
  • Kintai Therapeutics
  • MelliCell
  • Neurovalens
  • Noom
  • Oviva
  • Phenomix Sciences
  • Phyteau
  • ReShape Lifesciences
  • ValenTx
  • Viome
  • Zen Eating

List of Organizations Mentioned in the Report:

  • Advancing Research in Obesity (AIAARO)
  • American Board of Obesity Medicine
  • American Diabetes Association
  • American Obesity Association
  • American Obesity Treatment Association (AOTA)
  • Associacao Nacional de Assistencia ao Diabetico (ANAD, Brazil)
  • Association for the Study of Obesity
  • Association of the European Self-Medication Industry
  • Bariatric Surgery Society of India
  • Canadian Institute for Health Information
  • Center for Drug Evaluation and Research
  • European Association for the Study of Obesity (EASO)
  • European Medicines Agency
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • French Ministry of Health
  • International Diabetes Federation (IDF)
  • International Federation for the Surgery of Obesity and Metabolic Disorders
  • MD Anderson Cancer Center
  • Medicines and Healthcare products Regulatory Agency
  • Ministry of Health (MoH, Germany)
  • Ministry of Health, Labour and Welfare
  • Ministry of Health, Labour and Welfare (MHLW, Japan)
  • National Health Service (NHS, UK)
  • National Institute of Health and Clinical Excellence (NICE, UK)
  • Obesity Medicine Association
  • Pharmaceutical and Medical Devices Agency
  • Stanford University School of Medicine
  • State Food and Drug Administration
  • The Association for the Study of Obesity on the Island of Ireland (ASOI)
  • The International Association for the Study of Obesity
  • The Obesity Society
  • World Health Organization (WHO)
  • World Obesity Federation